BRPI0618926A2

BRPI0618926A2 - uso de um composto de ingenol ou um sal farmaceuticamente aceitável do mesmo

uso de um composto de ingenol ou um sal farmaceuticamente aceitável do mesmo Download PDF

Info

Publication number: BRPI0618926A2
Authority: BR; Brazil
Prior art keywords: euphorbia; wound; ingenol; optionally substituted; pharmaceutically acceptable
Prior art date: 2005-11-25

Application number

BRPI0618926-1A

Other languages

English (en)

Portuguese (pt)

Inventor

Steven Martin Ogbourne

David Thomas

Ryan Moseley

Original Assignee

Peplin Research Pty Ltd

Priority date

2005-11-25

Filing date

2006-11-24

Publication date

2011-09-13

2005-11-25 Priority claimed from AU2005906601A external-priority patent/AU2005906601A0/en

2006-11-24 Application filed by Peplin Research Pty Ltd filed Critical Peplin Research Pty Ltd

2011-09-13 Publication of BRPI0618926A2 publication Critical patent/BRPI0618926A2/pt

Links

-1 ingenol compound Chemical class 0.000 title claims abstract description 105
VEBVPUXQAPLADL-UHFFFAOYSA-N Ingenol Natural products C1=C(CO)C(O)C2(O)C(O)C(C)=CC32C(C)CC2C(C)(C)C2C1C3=O VEBVPUXQAPLADL-UHFFFAOYSA-N 0.000 title claims abstract description 44
150000003839 salts Chemical class 0.000 title claims abstract description 26
230000029663 wound healing Effects 0.000 claims abstract description 43
150000001875 compounds Chemical class 0.000 claims abstract description 32
208000027418 Wounds and injury Diseases 0.000 claims description 148
206010052428 Wound Diseases 0.000 claims description 103
229960002993 ingenol mebutate Drugs 0.000 claims description 90
VDJHFHXMUKFKET-UHFFFAOYSA-N Ingenol mebutate Natural products CC1CC2C(C)(C)C2C2C=C(CO)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O VDJHFHXMUKFKET-UHFFFAOYSA-N 0.000 claims description 86
VDJHFHXMUKFKET-WDUFCVPESA-N ingenol mebutate Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(CO)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O VDJHFHXMUKFKET-WDUFCVPESA-N 0.000 claims description 86
210000002950 fibroblast Anatomy 0.000 claims description 69
230000002500 effect on skin Effects 0.000 claims description 58
210000001519 tissue Anatomy 0.000 claims description 52
208000014674 injury Diseases 0.000 claims description 46
230000006378 damage Effects 0.000 claims description 45
102000004127 Cytokines Human genes 0.000 claims description 30
108090000695 Cytokines Proteins 0.000 claims description 30
210000003491 skin Anatomy 0.000 claims description 27
210000002510 keratinocyte Anatomy 0.000 claims description 24
238000004519 manufacturing process Methods 0.000 claims description 24
231100000241 scar Toxicity 0.000 claims description 21
125000000217 alkyl group Chemical group 0.000 claims description 16
239000003814 drug Substances 0.000 claims description 15
239000001257 hydrogen Substances 0.000 claims description 14
229910052739 hydrogen Inorganic materials 0.000 claims description 14
108090001005 Interleukin-6 Proteins 0.000 claims description 13
108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 13
125000003118 aryl group Chemical group 0.000 claims description 12
125000002252 acyl group Chemical group 0.000 claims description 11
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 10
125000003342 alkenyl group Chemical group 0.000 claims description 10
150000002431 hydrogen Chemical class 0.000 claims description 10
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims description 9
125000000304 alkynyl group Chemical group 0.000 claims description 9
125000003710 aryl alkyl group Chemical group 0.000 claims description 9
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
230000009120 phenotypic response Effects 0.000 claims description 9
108090001007 Interleukin-8 Proteins 0.000 claims description 8
230000001684 chronic effect Effects 0.000 claims description 8
206010072170 Skin wound Diseases 0.000 claims description 7
108010002350 Interleukin-2 Proteins 0.000 claims description 6
238000007906 compression Methods 0.000 claims description 6
230000006835 compression Effects 0.000 claims description 6
239000002537 cosmetic Substances 0.000 claims description 5
208000015181 infectious disease Diseases 0.000 claims description 5
239000000126 substance Substances 0.000 claims description 5
238000005299 abrasion Methods 0.000 claims description 4
230000001717 pathogenic effect Effects 0.000 claims description 4
UQOWJJGOQJONCI-UHFFFAOYSA-N 20-deoxyingenol-3-angelate Natural products CC1CC2C(C)(C)C2C2C=C(C)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O UQOWJJGOQJONCI-UHFFFAOYSA-N 0.000 claims description 3
UQOWJJGOQJONCI-MZRDIQIISA-N C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(C)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(C)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O UQOWJJGOQJONCI-MZRDIQIISA-N 0.000 claims description 3
208000002847 Surgical Wound Diseases 0.000 claims description 3
208000025865 Ulcer Diseases 0.000 claims description 3
125000004423 acyloxy group Chemical group 0.000 claims description 3
210000002784 stomach Anatomy 0.000 claims description 3
ZYCAGKYWXRKLSN-KLKWOBOISA-N C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(COC(C)=O)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(COC(C)=O)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O ZYCAGKYWXRKLSN-KLKWOBOISA-N 0.000 claims description 2
206010011026 Corneal lesion Diseases 0.000 claims description 2
208000034693 Laceration Diseases 0.000 claims description 2
238000002266 amputation Methods 0.000 claims description 2
125000002102 aryl alkyloxo group Chemical group 0.000 claims description 2
210000000988 bone and bone Anatomy 0.000 claims description 2
210000000845 cartilage Anatomy 0.000 claims description 2
206010012601 diabetes mellitus Diseases 0.000 claims description 2
125000003147 glycosyl group Chemical group 0.000 claims description 2
230000028993 immune response Effects 0.000 claims description 2
125000005017 substituted alkenyl group Chemical group 0.000 claims description 2
125000005415 substituted alkoxy group Chemical group 0.000 claims description 2
125000004426 substituted alkynyl group Chemical group 0.000 claims description 2
231100000397 ulcer Toxicity 0.000 claims description 2
125000005741 alkyl alkenyl group Chemical group 0.000 claims 1
230000002708 enhancing effect Effects 0.000 claims 1
230000000968 intestinal effect Effects 0.000 claims 1
238000000034 method Methods 0.000 abstract description 50
239000000203 mixture Substances 0.000 abstract description 33
VEBVPUXQAPLADL-POYOOMFHSA-N ingenol Chemical class C1=C(CO)[C@@H](O)[C@]2(O)[C@@H](O)C(C)=C[C@]32[C@H](C)C[C@H]2C(C)(C)[C@H]2[C@H]1C3=O VEBVPUXQAPLADL-POYOOMFHSA-N 0.000 abstract description 29
230000001737 promoting effect Effects 0.000 abstract description 8
241000221079 Euphorbia <genus> Species 0.000 description 119
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 71
210000004027 cell Anatomy 0.000 description 49
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 29
239000000499 gel Substances 0.000 description 29
210000005175 epidermal keratinocyte Anatomy 0.000 description 24
241001465754 Metazoa Species 0.000 description 23
102000008186 Collagen Human genes 0.000 description 21
108010035532 Collagen Proteins 0.000 description 21
239000001963 growth medium Substances 0.000 description 21
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 21
229920001436 collagen Polymers 0.000 description 20
230000035876 healing Effects 0.000 description 18
230000008569 process Effects 0.000 description 18
229940002612 prodrug Drugs 0.000 description 17
239000000651 prodrug Substances 0.000 description 17
241000196324 Embryophyta Species 0.000 description 15
239000000243 solution Substances 0.000 description 15
238000011282 treatment Methods 0.000 description 15
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 14
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 14
210000002744 extracellular matrix Anatomy 0.000 description 14
241000894007 species Species 0.000 description 13
239000006228 supernatant Substances 0.000 description 13
102000012422 Collagen Type I Human genes 0.000 description 12
108010022452 Collagen Type I Proteins 0.000 description 12
102000004889 Interleukin-6 Human genes 0.000 description 12
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
239000003795 chemical substances by application Substances 0.000 description 12
230000000694 effects Effects 0.000 description 12
230000001965 increasing effect Effects 0.000 description 12
239000011159 matrix material Substances 0.000 description 12
239000002609 medium Substances 0.000 description 12
239000004480 active ingredient Substances 0.000 description 11
239000012298 atmosphere Substances 0.000 description 11
238000011156 evaluation Methods 0.000 description 11
229940100601 interleukin-6 Drugs 0.000 description 11
108091003079 Bovine Serum Albumin Proteins 0.000 description 10
230000008521 reorganization Effects 0.000 description 10
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 9
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
102000002274 Matrix Metalloproteinases Human genes 0.000 description 9
108010000684 Matrix Metalloproteinases Proteins 0.000 description 9
230000016396 cytokine production Effects 0.000 description 9
210000004207 dermis Anatomy 0.000 description 9
241000700159 Rattus Species 0.000 description 8
239000003102 growth factor Substances 0.000 description 8
239000007788 liquid Substances 0.000 description 8
108090000623 proteins and genes Proteins 0.000 description 8
230000000638 stimulation Effects 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
240000001837 Euphorbia peplus Species 0.000 description 7
241000221017 Euphorbiaceae Species 0.000 description 7
102000016359 Fibronectins Human genes 0.000 description 7
102000004890 Interleukin-8 Human genes 0.000 description 7
238000004458 analytical method Methods 0.000 description 7
230000008602 contraction Effects 0.000 description 7
230000003247 decreasing effect Effects 0.000 description 7
229940079593 drug Drugs 0.000 description 7
210000002615 epidermis Anatomy 0.000 description 7
238000000338 in vitro Methods 0.000 description 7
238000011534 incubation Methods 0.000 description 7
230000001105 regulatory effect Effects 0.000 description 7
230000037390 scarring Effects 0.000 description 7
125000001424 substituent group Chemical group 0.000 description 7
239000000725 suspension Substances 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
206010015150 Erythema Diseases 0.000 description 6
108010067306 Fibronectins Proteins 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
229940098773 bovine serum albumin Drugs 0.000 description 6
239000000872 buffer Substances 0.000 description 6
239000000969 carrier Substances 0.000 description 6
230000001413 cellular effect Effects 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
230000014509 gene expression Effects 0.000 description 6
239000000463 material Substances 0.000 description 6
230000005012 migration Effects 0.000 description 6
238000013508 migration Methods 0.000 description 6
230000036961 partial effect Effects 0.000 description 6
239000000902 placebo Substances 0.000 description 6
229940068196 placebo Drugs 0.000 description 6
239000000843 powder Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
230000035755 proliferation Effects 0.000 description 6
102000004169 proteins and genes Human genes 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
239000003826 tablet Substances 0.000 description 6
101710151806 72 kDa type IV collagenase Proteins 0.000 description 5
102100026802 72 kDa type IV collagenase Human genes 0.000 description 5
244000067602 Chamaesyce hirta Species 0.000 description 5
102000000588 Interleukin-2 Human genes 0.000 description 5
230000001154 acute effect Effects 0.000 description 5
125000005601 angeloyl group Chemical group 0.000 description 5
210000002469 basement membrane Anatomy 0.000 description 5
230000012292 cell migration Effects 0.000 description 5
230000004663 cell proliferation Effects 0.000 description 5
125000000753 cycloalkyl group Chemical group 0.000 description 5
230000004069 differentiation Effects 0.000 description 5
230000036541 health Effects 0.000 description 5
230000004054 inflammatory process Effects 0.000 description 5
210000002540 macrophage Anatomy 0.000 description 5
230000000699 topical effect Effects 0.000 description 5
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 4
241000699666 Mus <mouse, genus> Species 0.000 description 4
239000003242 anti bacterial agent Substances 0.000 description 4
239000002585 base Substances 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
230000009693 chronic damage Effects 0.000 description 4
230000007423 decrease Effects 0.000 description 4
239000000284 extract Substances 0.000 description 4
239000012894 fetal calf serum Substances 0.000 description 4
238000009472 formulation Methods 0.000 description 4
239000008187 granular material Substances 0.000 description 4
230000003810 hyperpigmentation Effects 0.000 description 4
208000000069 hyperpigmentation Diseases 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
230000003993 interaction Effects 0.000 description 4
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
238000007634 remodeling Methods 0.000 description 4
230000004044 response Effects 0.000 description 4
239000011550 stock solution Substances 0.000 description 4
235000000346 sugar Nutrition 0.000 description 4
230000035899 viability Effects 0.000 description 4
239000011534 wash buffer Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
102000007469 Actins Human genes 0.000 description 3
108010085238 Actins Proteins 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
206010063560 Excessive granulation tissue Diseases 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
208000003367 Hypopigmentation Diseases 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
102100040247 Tumor necrosis factor Human genes 0.000 description 3
238000002835 absorbance Methods 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000010933 acylation Effects 0.000 description 3
238000005917 acylation reaction Methods 0.000 description 3
238000003556 assay Methods 0.000 description 3
239000011324 bead Substances 0.000 description 3
229960000074 biopharmaceutical Drugs 0.000 description 3
210000001772 blood platelet Anatomy 0.000 description 3
210000004204 blood vessel Anatomy 0.000 description 3
239000006285 cell suspension Substances 0.000 description 3
230000003833 cell viability Effects 0.000 description 3
239000006071 cream Substances 0.000 description 3
230000002354 daily effect Effects 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
210000002919 epithelial cell Anatomy 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
230000001605 fetal effect Effects 0.000 description 3
125000000524 functional group Chemical group 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
210000001126 granulation tissue Anatomy 0.000 description 3
238000003306 harvesting Methods 0.000 description 3
230000003425 hypopigmentation Effects 0.000 description 3
230000006872 improvement Effects 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
238000002955 isolation Methods 0.000 description 3
230000035800 maturation Effects 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
230000037311 normal skin Effects 0.000 description 3
239000002674 ointment Substances 0.000 description 3
239000006072 paste Substances 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000036573 scar formation Effects 0.000 description 3
210000001626 skin fibroblast Anatomy 0.000 description 3
230000004936 stimulating effect Effects 0.000 description 3
238000012360 testing method Methods 0.000 description 3
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
JHORJRSRQZDYPZ-UHFFFAOYSA-N 1,1,4,7,9-pentamethyldodecahydro-1h-2,8a-methanocyclopenta[a]cyclopropa[e][10]annulene Chemical class CC1CC2C(C)(C)C2C2CC(C)CC3CC(C)CC31C2 JHORJRSRQZDYPZ-UHFFFAOYSA-N 0.000 description 2
WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 2
QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 2
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 2
241000700198 Cavia Species 0.000 description 2
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
239000005977 Ethylene Substances 0.000 description 2
244000106376 Euphorbia hypericifolia Species 0.000 description 2
241001553687 Euphorbia misella Species 0.000 description 2
208000010201 Exanthema Diseases 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
102000013382 Gelatinases Human genes 0.000 description 2
108010026132 Gelatinases Proteins 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
241000558295 Homalanthus Species 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
206010061245 Internal injury Diseases 0.000 description 2
102000011782 Keratins Human genes 0.000 description 2
108010076876 Keratins Proteins 0.000 description 2
208000005230 Leg Ulcer Diseases 0.000 description 2
102000005741 Metalloproteases Human genes 0.000 description 2
108010006035 Metalloproteases Proteins 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Natural products N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
239000004107 Penicillin G sodium Substances 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
208000012641 Pigmentation disease Diseases 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
102000012479 Serine Proteases Human genes 0.000 description 2
108010022999 Serine Proteases Proteins 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
102000013127 Vimentin Human genes 0.000 description 2
108010065472 Vimentin Proteins 0.000 description 2
230000001133 acceleration Effects 0.000 description 2
208000009621 actinic keratosis Diseases 0.000 description 2
239000013543 active substance Substances 0.000 description 2
230000002411 adverse Effects 0.000 description 2
230000029936 alkylation Effects 0.000 description 2
238000005804 alkylation reaction Methods 0.000 description 2
238000005905 alkynylation reaction Methods 0.000 description 2
230000004075 alteration Effects 0.000 description 2
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 2
229960003942 amphotericin b Drugs 0.000 description 2
150000008064 anhydrides Chemical class 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
230000001093 anti-cancer Effects 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000003429 antifungal agent Substances 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
239000003899 bactericide agent Substances 0.000 description 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 2
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000032823 cell division Effects 0.000 description 2
230000010261 cell growth Effects 0.000 description 2
230000001889 chemoattractive effect Effects 0.000 description 2
238000000576 coating method Methods 0.000 description 2
239000003636 conditioned culture medium Substances 0.000 description 2
210000002808 connective tissue Anatomy 0.000 description 2
239000013078 crystal Substances 0.000 description 2
150000008050 dialkyl sulfates Chemical class 0.000 description 2
DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 2
229940008406 diethyl sulfate Drugs 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
CJYQQUPRURWLOW-YDLUHMIOSA-M dmsc Chemical compound [Na+].OP(=O)=O.OP(=O)=O.OP(=O)=O.[O-]P(=O)=O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O CJYQQUPRURWLOW-YDLUHMIOSA-M 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
210000000981 epithelium Anatomy 0.000 description 2
231100000321 erythema Toxicity 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
201000005884 exanthem Diseases 0.000 description 2
238000000684 flow cytometry Methods 0.000 description 2
239000006260 foam Substances 0.000 description 2
235000013305 food Nutrition 0.000 description 2
230000006870 function Effects 0.000 description 2
238000005469 granulation Methods 0.000 description 2
230000003179 granulation Effects 0.000 description 2
230000012010 growth Effects 0.000 description 2
150000004820 halides Chemical class 0.000 description 2
230000023597 hemostasis Effects 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
230000003308 immunostimulating effect Effects 0.000 description 2
230000001771 impaired effect Effects 0.000 description 2
210000004969 inflammatory cell Anatomy 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
230000028709 inflammatory response Effects 0.000 description 2
230000016507 interphase Effects 0.000 description 2
239000011344 liquid material Substances 0.000 description 2
239000006210 lotion Substances 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
210000001616 monocyte Anatomy 0.000 description 2
238000000465 moulding Methods 0.000 description 2
210000000651 myofibroblast Anatomy 0.000 description 2
125000001624 naphthyl group Chemical group 0.000 description 2
230000001338 necrotic effect Effects 0.000 description 2
210000000440 neutrophil Anatomy 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
239000003921 oil Substances 0.000 description 2
206010033675 panniculitis Diseases 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
235000019369 penicillin G sodium Nutrition 0.000 description 2
229940056360 penicillin g Drugs 0.000 description 2
230000019612 pigmentation Effects 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000000770 proinflammatory effect Effects 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
235000019833 protease Nutrition 0.000 description 2
238000001303 quality assessment method Methods 0.000 description 2
206010037844 rash Diseases 0.000 description 2
230000037309 reepithelialization Effects 0.000 description 2
230000008439 repair process Effects 0.000 description 2
230000001850 reproductive effect Effects 0.000 description 2
230000036548 skin texture Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
229960002385 streptomycin sulfate Drugs 0.000 description 2
210000004304 subcutaneous tissue Anatomy 0.000 description 2
125000000547 substituted alkyl group Chemical group 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
210000002435 tendon Anatomy 0.000 description 2
239000002562 thickening agent Substances 0.000 description 2
210000005048 vimentin Anatomy 0.000 description 2
238000005406 washing Methods 0.000 description 2
PQMFVUNERGGBPG-UHFFFAOYSA-N (6-bromopyridin-2-yl)hydrazine Chemical compound NNC1=CC=CC(Br)=N1 PQMFVUNERGGBPG-UHFFFAOYSA-N 0.000 description 1
125000003837 (C1-C20) alkyl group Chemical group 0.000 description 1
125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 1
125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 1
YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical class CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
125000006039 1-hexenyl group Chemical group 0.000 description 1
125000006023 1-pentenyl group Chemical group 0.000 description 1
125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
125000003562 2,2-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
125000005916 2-methylpentyl group Chemical group 0.000 description 1
LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
125000004336 3,3-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
125000006041 3-hexenyl group Chemical group 0.000 description 1
125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
125000005917 3-methylpentyl group Chemical group 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
241001249944 Abbreviata Species 0.000 description 1
241001060350 Acalypha Species 0.000 description 1
241000933112 Acidoton Species 0.000 description 1
208000002874 Acne Vulgaris Diseases 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
241001300714 Actinostemon Species 0.000 description 1
241001303063 Adelia <angiosperm> Species 0.000 description 1
241001303039 Adenocline Species 0.000 description 1
241001300216 Adenophaedra Species 0.000 description 1
241001554343 Agrostistachys Species 0.000 description 1
241000545417 Aleurites Species 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
235000015072 Antidesma Nutrition 0.000 description 1
241000785806 Antidesma Species 0.000 description 1
241001249101 Aporosa Species 0.000 description 1
241000310770 Argythamnia Species 0.000 description 1
241000271566 Aves Species 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241001300062 Baliospermum Species 0.000 description 1
241000558349 Bernardia Species 0.000 description 1
241000978490 Bistorta Species 0.000 description 1
241001300698 Bonania Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
101001027553 Bos taurus Fibronectin Proteins 0.000 description 1
101000766308 Bos taurus Serotransferrin Proteins 0.000 description 1
241000785605 Bridelia Species 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
125000003358 C2-C20 alkenyl group Chemical group 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 1
241000944318 Cheilosa Species 0.000 description 1
208000018380 Chemical injury Diseases 0.000 description 1
241001300185 Chiropetalum Species 0.000 description 1
GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
241000207199 Citrus Species 0.000 description 1
241000785597 Cleistanthus Species 0.000 description 1
241001300651 Cnesmone Species 0.000 description 1
241000990192 Codiaeum Species 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
229920002785 Croscarmellose sodium Polymers 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
241001554488 Dalechampia Species 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
208000008960 Diabetic foot Diseases 0.000 description 1
241000266013 Dimorphocalyx Species 0.000 description 1
241000819742 Ditaxis <mantid lacewing> Species 0.000 description 1
SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
241001060713 Drypetes Species 0.000 description 1
241000558350 Dysopsis Species 0.000 description 1
241001554477 Elateriospermum Species 0.000 description 1
241000558344 Endospermum Species 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000016998 Erismanthus Species 0.000 description 1
241001553302 Euphorbia aaron-rossii Species 0.000 description 1
241000116144 Euphorbia acuta Species 0.000 description 1
241001373703 Euphorbia arabica Species 0.000 description 1
241001373446 Euphorbia arizonica Species 0.000 description 1
241001191295 Euphorbia arteagae Species 0.000 description 1
241001191291 Euphorbia brachiata Species 0.000 description 1
241001373282 Euphorbia capitellata Species 0.000 description 1
241001373278 Euphorbia carmenensis Species 0.000 description 1
241001553150 Euphorbia carunculata Species 0.000 description 1
241001599902 Euphorbia celastroides Species 0.000 description 1
241001373713 Euphorbia chamaerrhodos Species 0.000 description 1
241000210641 Euphorbia chamaesula Species 0.000 description 1
241000210643 Euphorbia creberrima Species 0.000 description 1
241000210644 Euphorbia crenulata Species 0.000 description 1
241001599887 Euphorbia cubensis Species 0.000 description 1
244000048459 Euphorbia cyathophora Species 0.000 description 1
241000498739 Euphorbia dussii Species 0.000 description 1
241001553564 Euphorbia eanophylla Species 0.000 description 1
241001553561 Euphorbia eglandulosa Species 0.000 description 1
241000221085 Euphorbia esula Species 0.000 description 1
241001553525 Euphorbia exstipulata Species 0.000 description 1
241001373250 Euphorbia fendleri Species 0.000 description 1
241001553506 Euphorbia gradyi Species 0.000 description 1
241001300734 Euphorbia guentheri Species 0.000 description 1
241001553803 Euphorbia hedyotoides Species 0.000 description 1
241000789809 Euphorbia helenae Species 0.000 description 1
241000210605 Euphorbia helleri Species 0.000 description 1
241001191145 Euphorbia hexagona Species 0.000 description 1
241001191128 Euphorbia hinkleyorum Species 0.000 description 1
241000072948 Euphorbia humistrata Species 0.000 description 1
241001553793 Euphorbia juttae Species 0.000 description 1
241001373338 Euphorbia lasiocarpa Species 0.000 description 1
241001373340 Euphorbia lata Species 0.000 description 1
241000355770 Euphorbia lugardae Species 0.000 description 1
241000704053 Euphorbia lurida Species 0.000 description 1
241001191122 Euphorbia lycioides Species 0.000 description 1
241001191117 Euphorbia macropodoides Species 0.000 description 1
241001373324 Euphorbia mendezii Species 0.000 description 1
241001373328 Euphorbia micromera Species 0.000 description 1
241001373330 Euphorbia missurica Species 0.000 description 1
241001600122 Euphorbia nutans Species 0.000 description 1
241001553675 Euphorbia oaxacana Species 0.000 description 1
241001373312 Euphorbia olowaluana Species 0.000 description 1
241001373304 Euphorbia pediculifera Species 0.000 description 1
241000210612 Euphorbia peplidion Species 0.000 description 1
241001373298 Euphorbia perlignea Species 0.000 description 1
241001600106 Euphorbia poeppigii Species 0.000 description 1
241001373071 Euphorbia polycarpa Species 0.000 description 1
241001553145 Euphorbia polycnemoides Species 0.000 description 1
241001191099 Euphorbia polyphylla Species 0.000 description 1
241000704074 Euphorbia portulacoides Species 0.000 description 1
241000652460 Euphorbia procumbens Species 0.000 description 1
244000062608 Euphorbia prostrata Species 0.000 description 1
241001553778 Euphorbia pteroneura Species 0.000 description 1
241000097488 Euphorbia rapulum Species 0.000 description 1
241001373694 Euphorbia remyi Species 0.000 description 1
241001553755 Euphorbia robusta Species 0.000 description 1
241000210614 Euphorbia schizoloba Species 0.000 description 1
241001553742 Euphorbia segoviensis Species 0.000 description 1
241000244736 Euphorbia serpillifolia Species 0.000 description 1
241001373182 Euphorbia serrula Species 0.000 description 1
241001373183 Euphorbia setiloba Species 0.000 description 1
241001553739 Euphorbia sonorae Species 0.000 description 1
241001191091 Euphorbia soobyi Species 0.000 description 1
241001600080 Euphorbia stellata Species 0.000 description 1
241001553723 Euphorbia subpeltata Species 0.000 description 1
241001553722 Euphorbia succedanea Species 0.000 description 1
241000500281 Euphorbia telephioides Species 0.000 description 1
241000210615 Euphorbia tetrapora Species 0.000 description 1
241001373689 Euphorbia trachysperma Species 0.000 description 1
241000704100 Euphorbia umbellata Species 0.000 description 1
206010015548 Euthanasia Diseases 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
241000785753 Flueggea Species 0.000 description 1
208000003790 Foot Ulcer Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000051366 Glycosyltransferases Human genes 0.000 description 1
108700023372 Glycosyltransferases Proteins 0.000 description 1
241000608174 Gymnadenia Species 0.000 description 1
244000043261 Hevea brasiliensis Species 0.000 description 1
240000004153 Hibiscus sabdariffa Species 0.000 description 1
241000869029 Hieronyma Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
206010022714 Intestinal ulcer Diseases 0.000 description 1
241000221089 Jatropha Species 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
235000000421 Lepidium meyenii Nutrition 0.000 description 1
240000000759 Lepidium meyenii Species 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
208000002720 Malnutrition Diseases 0.000 description 1
108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
241000404165 Microcephala Species 0.000 description 1
102000002151 Microfilament Proteins Human genes 0.000 description 1
206010028034 Mouth ulceration Diseases 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
206010030113 Oedema Diseases 0.000 description 1
241000870767 Omphalea Species 0.000 description 1
241001300642 Ophellantha Species 0.000 description 1
208000007117 Oral Ulcer Diseases 0.000 description 1
241000558287 Ostodes Species 0.000 description 1
241001300042 Pausandra Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241001387969 Petalostigma Species 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
241001130943 Phyllanthus <Aves> Species 0.000 description 1
241001300673 Platygyna Species 0.000 description 1
241001300677 Plukenetia Species 0.000 description 1
101100505672 Podospora anserina grisea gene Proteins 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
102000017033 Porins Human genes 0.000 description 1
108010013381 Porins Proteins 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
208000004210 Pressure Ulcer Diseases 0.000 description 1
241000288906 Primates Species 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
235000014443 Pyrus communis Nutrition 0.000 description 1
240000001987 Pyrus communis Species 0.000 description 1
102000042463 Rho family Human genes 0.000 description 1
108091078243 Rho family Proteins 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
101100500563 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ECM5 gene Proteins 0.000 description 1
241001300086 Sagotia Species 0.000 description 1
241000994241 Sapium Species 0.000 description 1
241000785917 Savia Species 0.000 description 1
101100019493 Schizosaccharomyces pombe (strain 972 / ATCC 24843) jmj3 gene Proteins 0.000 description 1
244000078613 Scirpus geniculatus Species 0.000 description 1
241001301432 Sclerocroton Species 0.000 description 1
241000867909 Securinega Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
208000000453 Skin Neoplasms Diseases 0.000 description 1
206010040865 Skin hyperpigmentation Diseases 0.000 description 1
206010040868 Skin hypopigmentation Diseases 0.000 description 1
208000028990 Skin injury Diseases 0.000 description 1
102000013275 Somatomedins Human genes 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
208000007107 Stomach Ulcer Diseases 0.000 description 1
241000282887 Suidae Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
241001537924 Tetracoccus <angiosperm> Species 0.000 description 1
241001300663 Tetraplandra Species 0.000 description 1
241000870728 Tetrorchidium Species 0.000 description 1
241001300199 Thyrsanthera Species 0.000 description 1
241000870682 Trigonostemon Species 0.000 description 1
241000789056 Tyria Species 0.000 description 1
206010047139 Vasoconstriction Diseases 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
206010000496 acne Diseases 0.000 description 1
108091000387 actin binding proteins Proteins 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000009692 acute damage Effects 0.000 description 1
230000010398 acute inflammatory response Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
239000003513 alkali Substances 0.000 description 1
125000003282 alkyl amino group Chemical group 0.000 description 1
125000005210 alkyl ammonium group Chemical group 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000001153 anti-wrinkle effect Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
125000001124 arachidoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
125000003435 aroyl group Chemical group 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
125000003828 azulenyl group Chemical group 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
230000002051 biphasic effect Effects 0.000 description 1
239000004305 biphenyl Substances 0.000 description 1
235000010290 biphenyl Nutrition 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
150000001649 bromium compounds Chemical class 0.000 description 1
125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
244000309466 calf Species 0.000 description 1
239000002775 capsule Substances 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
229940081733 cetearyl alcohol Drugs 0.000 description 1
230000008859 change Effects 0.000 description 1
208000022469 change in skin texture Diseases 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
229960003260 chlorhexidine Drugs 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
229920003211 cis-1,4-polyisoprene Polymers 0.000 description 1
235000020971 citrus fruits Nutrition 0.000 description 1
210000000078 claw Anatomy 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
230000037319 collagen production Effects 0.000 description 1
229940096422 collagen type i Drugs 0.000 description 1
239000002131 composite material Substances 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
125000006639 cyclohexyl carbonyl group Chemical group 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000006547 cyclononyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
125000006638 cyclopentyl carbonyl group Chemical group 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
KAATUXNTWXVJKI-UHFFFAOYSA-N cypermethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 KAATUXNTWXVJKI-UHFFFAOYSA-N 0.000 description 1
230000003436 cytoskeletal effect Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
238000001804 debridement Methods 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000003405 delayed action preparation Substances 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
229960002986 dinoprostone Drugs 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002612 dispersion medium Substances 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000012154 double-distilled water Substances 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000004043 dyeing Methods 0.000 description 1
239000008387 emulsifying waxe Substances 0.000 description 1
239000002702 enteric coating Substances 0.000 description 1
238000009505 enteric coating Methods 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
230000009786 epithelial differentiation Effects 0.000 description 1
210000005081 epithelial layer Anatomy 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000011536 extraction buffer Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
210000000630 fibrocyte Anatomy 0.000 description 1
239000012997 ficoll-paque Substances 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000010408 film Substances 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
125000001153 fluoro group Chemical group F* 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
239000004459 forage Substances 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
150000002243 furanoses Chemical class 0.000 description 1
150000002256 galaktoses Chemical class 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000007804 gelatin zymography Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
229930182470 glycoside Natural products 0.000 description 1
150000002338 glycosides Chemical class 0.000 description 1
210000004209 hair Anatomy 0.000 description 1
210000003780 hair follicle Anatomy 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
125000004970 halomethyl group Chemical group 0.000 description 1
BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 1
229960003132 halothane Drugs 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229940116978 human epidermal growth factor Drugs 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
239000000416 hydrocolloid Substances 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
239000007943 implant Substances 0.000 description 1
208000038020 incisional injury Diseases 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000003701 inert diluent Substances 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000009434 installation Methods 0.000 description 1
102000006495 integrins Human genes 0.000 description 1
108010044426 integrins Proteins 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
230000019189 interleukin-1 beta production Effects 0.000 description 1
230000004073 interleukin-2 production Effects 0.000 description 1
230000017306 interleukin-6 production Effects 0.000 description 1
230000021995 interleukin-8 production Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000004694 iodide salts Chemical class 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
230000003780 keratinization Effects 0.000 description 1
230000029774 keratinocyte migration Effects 0.000 description 1
210000001821 langerhans cell Anatomy 0.000 description 1
125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
235000012902 lepidium meyenii Nutrition 0.000 description 1
230000003902 lesion Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
229930186179 lupulin Natural products 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000001071 malnutrition Effects 0.000 description 1
235000000824 malnutrition Nutrition 0.000 description 1
125000000628 margaroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
210000002752 melanocyte Anatomy 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000000716 merkel cell Anatomy 0.000 description 1
210000003632 microfilament Anatomy 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
239000007932 molded tablet Substances 0.000 description 1
230000004784 molecular pathogenesis Effects 0.000 description 1
125000002950 monocyclic group Chemical group 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
229940051866 mouthwash Drugs 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
210000001640 nerve ending Anatomy 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
239000012457 nonaqueous media Substances 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
208000015380 nutritional deficiency disease Diseases 0.000 description 1
125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
125000004430 oxygen atom Chemical group O* 0.000 description 1
IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
125000006194 pentinyl group Chemical group 0.000 description 1
230000003239 periodontal effect Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
125000004346 phenylpentyl group Chemical group C1(=CC=CC=C1)CCCCC* 0.000 description 1
125000004344 phenylpropyl group Chemical group 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
239000011505 plaster Substances 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001451 polypropylene glycol Polymers 0.000 description 1
229940113124 polysorbate 60 Drugs 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
125000006308 propyl amino group Chemical group 0.000 description 1
XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
150000003214 pyranose derivatives Chemical class 0.000 description 1
125000001725 pyrenyl group Chemical group 0.000 description 1
238000013441 quality evaluation Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000008929 regeneration Effects 0.000 description 1
238000011069 regeneration method Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000035807 sensation Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000012679 serum free medium Substances 0.000 description 1
239000004017 serum-free culture medium Substances 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
238000007390 skin biopsy Methods 0.000 description 1
201000000849 skin cancer Diseases 0.000 description 1
231100000046 skin rash Toxicity 0.000 description 1
238000002791 soaking Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229940079832 sodium starch glycolate Drugs 0.000 description 1
239000008109 sodium starch glycolate Substances 0.000 description 1
229920003109 sodium starch glycolate Polymers 0.000 description 1
239000012453 solvate Substances 0.000 description 1
239000001587 sorbitan monostearate Substances 0.000 description 1
235000011076 sorbitan monostearate Nutrition 0.000 description 1
229940035048 sorbitan monostearate Drugs 0.000 description 1
238000012453 sprague-dawley rat model Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000013517 stratification Methods 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000013589 supplement Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
230000028016 temperature homeostasis Effects 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
230000009772 tissue formation Effects 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
125000005425 toluyl group Chemical group 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
229940126702 topical medication Drugs 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000010474 transient expression Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
229930187845 trigonostemon Natural products 0.000 description 1
230000006433 tumor necrosis factor production Effects 0.000 description 1
230000036269 ulceration Effects 0.000 description 1
125000000297 undecanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000004417 unsaturated alkyl group Chemical group 0.000 description 1
125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000025033 vasoconstriction Effects 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
210000001835 viscera Anatomy 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000001993 wax Substances 0.000 description 1
238000009941 weaving Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000005303 weighing Methods 0.000 description 1
230000010388 wound contraction Effects 0.000 description 1
238000007805 zymography Methods 0.000 description 1